Agenus shares surge as company secures up to $340M to advance colon cancer trial
Agenus shares surge as company secures up to $340M to advance colon cancer trial
Agenus shares surge as company secures up to $340M to advance colon cancer trial
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.